Position in ALKS
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$11,224,464
+$2,041,290 QoQ
Shares Held
317,434
-3.3% QoQ
Ownership
0.190%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 75.04426116925093.ToString("F0")%
Shared 0.ToString("F0")%
None 24.95573883074907.ToString("F0")%
Common Shares in ALKS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026RAYMOND JAMES FINANCIAL INC holds $784,401,544 across 37 Drug Manufacturers - Specialty & Generic names. ALKS ranks #9 (1.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
3,166,615 | $374,325,557 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
601,487 | $79,239,894 | |
| 3 | HLN |
Haleon plc
|
6,264,041 | $62,703,048 | |
| 4 | TEVA |
Teva Pharmaceutical Industries Ltd
|
1,816,715 | $54,719,453 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
1,898,337 | $45,427,201 | |
| 6 | PBH |
Prestige Consumer Healthcare Inc.
|
556,460 | $32,981,383 | |
| 7 | UTHR |
UNITED THERAPEUTICS Corp
|
47,576 | $28,211,615 | |
| 8 | VTRS |
Viatris Inc
|
1,855,553 | $25,068,518 |
All Filings in ALKS
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $11,224,464 | 317,434 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $9,183,174 | 328,205 | Shares | Defined | 2026-02-18 | |
| 2025-09-30 | $13,407,750 | 446,925 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $13,000,869 | 454,417 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $14,181,494 | 429,482 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $12,292,655 | 427,422 | Shares | Defined | 2025-04-23 | |
| No filing history on record for this holder in this stock. | ||||||